NO20051658L - Terapeutisk behandling - Google Patents
Terapeutisk behandlingInfo
- Publication number
- NO20051658L NO20051658L NO20051658A NO20051658A NO20051658L NO 20051658 L NO20051658 L NO 20051658L NO 20051658 A NO20051658 A NO 20051658A NO 20051658 A NO20051658 A NO 20051658A NO 20051658 L NO20051658 L NO 20051658L
- Authority
- NO
- Norway
- Prior art keywords
- therapeutic treatment
- pharmaceutically acceptable
- acceptable salt
- disclosed
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
2005-05-06 SAMMENDRAG Kombinasjon, omfattende en endotelin reseptorantagonist eller et farmasøytisk akseptabelt salt derav og en EGFR TKI eller et farmasøytisk 5. akseptabelt salt derav er beskrevet.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0223854.1A GB0223854D0 (en) | 2002-10-12 | 2002-10-12 | Therapeutic treatment |
PCT/GB2003/004347 WO2004035057A1 (en) | 2002-10-12 | 2003-10-07 | Therapeutic treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20051658L true NO20051658L (no) | 2005-05-06 |
Family
ID=9945876
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20051658A NO20051658L (no) | 2002-10-12 | 2005-04-04 | Terapeutisk behandling |
Country Status (30)
Country | Link |
---|---|
US (1) | US20060122180A1 (no) |
EP (1) | EP1553950B1 (no) |
JP (1) | JP2006510605A (no) |
KR (1) | KR20050056238A (no) |
CN (1) | CN100342853C (no) |
AR (1) | AR041595A1 (no) |
AT (1) | ATE369136T1 (no) |
AU (1) | AU2003269259B2 (no) |
BR (1) | BR0315140A (no) |
CA (1) | CA2501959A1 (no) |
CY (1) | CY1107605T1 (no) |
DE (1) | DE60315490T2 (no) |
DK (1) | DK1553950T3 (no) |
ES (1) | ES2289316T3 (no) |
GB (1) | GB0223854D0 (no) |
HK (1) | HK1078784A1 (no) |
IS (1) | IS2473B (no) |
MX (1) | MXPA05003808A (no) |
MY (1) | MY135441A (no) |
NO (1) | NO20051658L (no) |
NZ (1) | NZ539137A (no) |
PL (1) | PL375584A1 (no) |
PT (1) | PT1553950E (no) |
RU (1) | RU2005114487A (no) |
SA (1) | SA04240502B1 (no) |
TW (1) | TW200412971A (no) |
UA (1) | UA82492C2 (no) |
UY (1) | UY28017A1 (no) |
WO (1) | WO2004035057A1 (no) |
ZA (1) | ZA200502874B (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0218526D0 (en) * | 2002-08-09 | 2002-09-18 | Astrazeneca Ab | Combination therapy |
GB0219660D0 (en) | 2002-08-23 | 2002-10-02 | Astrazeneca Ab | Therapeutic use |
WO2004100991A1 (en) * | 2003-05-15 | 2004-11-25 | Universite Catholique De Louvain | Use of endothelin-1 antagonists for improving cancer therapy |
GB0320806D0 (en) * | 2003-09-05 | 2003-10-08 | Astrazeneca Ab | Therapeutic treatment |
GB0403744D0 (en) | 2004-02-20 | 2004-03-24 | Astrazeneca Ab | Chemical process |
GB0425854D0 (en) * | 2004-11-25 | 2004-12-29 | Astrazeneca Ab | Therapeutic treatment |
KR20100099113A (ko) * | 2007-10-12 | 2010-09-10 | 아스트라제네카 아베 | 만니톨 및/또는 미세결정질 셀룰로스를 포함하는 지보텐탄 조성물 |
TWI483938B (zh) * | 2009-08-10 | 2015-05-11 | Univ Texas | 以內皮素受體抑制劑處理星狀腫瘤細胞 |
WO2021011925A1 (en) * | 2019-07-17 | 2021-01-21 | Enb Therapeutics, Inc. | Treatment of urothelial and kidney cancers by use of endothelin b receptor antagonists |
BR112023019460A2 (pt) | 2021-06-22 | 2024-01-23 | Alchemedicine Inc | Composto, antagonista do receptor de endotelina a e composição farmacêutica que compreendem o mesmo e usos do composto como terapia e na produção de um antagonista do receptor de endotelina a |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5514691A (en) * | 1993-05-20 | 1996-05-07 | Immunopharmaceutics, Inc. | N-(4-halo-isoxazolyl)-sulfonamides and derivatives thereof that modulate the activity of endothelin |
US5464853A (en) * | 1993-05-20 | 1995-11-07 | Immunopharmaceutics, Inc. | N-(5-isoxazolyl)biphenylsulfonamides, N-(3-isoxazolyl)biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
AU661533B2 (en) * | 1992-01-20 | 1995-07-27 | Astrazeneca Ab | Quinazoline derivatives |
US6063911A (en) * | 1993-12-01 | 2000-05-16 | Marine Polymer Technologies, Inc. | Methods and compositions for treatment of cell proliferative disorders |
GB9508538D0 (en) * | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
UA58494C2 (uk) * | 1995-06-07 | 2003-08-15 | Зенека Лімітед | Похідні n-гетероарилпіридинсульфонаміду, фармацевтична композиція, спосіб одержання та спосіб протидії впливам ендотеліну |
US5780435A (en) * | 1995-12-15 | 1998-07-14 | Praecis Pharmaceuticals Incorporated | Methods for treating prostate cancer with LHRH-R antagonists |
JP4652569B2 (ja) * | 1998-04-29 | 2011-03-16 | オーエスアイ・ファーマスーティカルズ・インコーポレーテッド | N−(3−エチニルフェニルアミノ)−6,7−ビス(2−メトキシエトキシ)−4−キナゾリンアミンメシレートの無水物及び一水和物 |
US6355678B1 (en) * | 1998-06-29 | 2002-03-12 | Parker Hughes Institute | Inhibitors of the EGF-receptor tyrosine kinase and methods for their use |
GB0008368D0 (en) * | 2000-04-06 | 2000-05-24 | Astrazeneca Ab | Combination product |
US20020055457A1 (en) * | 2000-08-07 | 2002-05-09 | Janus Todd J. | Methods of treating cancer and the pain associated therewith using endothelin antagonists |
US20030092757A1 (en) * | 2001-04-11 | 2003-05-15 | Amitabh Singh | Favorable modulation of health-related quality of life and health-related quality-adjusted time-to-progression of disease in patients with prostate cancer |
DE10155076A1 (de) * | 2001-11-09 | 2003-05-22 | Merck Patent Gmbh | Verwendung von Endothelin-Rezeptor-Antagonisten zur Behandlung von Tumorerkrankungen |
-
2002
- 2002-10-12 GB GBGB0223854.1A patent/GB0223854D0/en not_active Ceased
-
2003
- 2003-07-10 UA UAA200504329A patent/UA82492C2/uk unknown
- 2003-10-07 CA CA002501959A patent/CA2501959A1/en not_active Abandoned
- 2003-10-07 JP JP2004544431A patent/JP2006510605A/ja active Pending
- 2003-10-07 EP EP03751038A patent/EP1553950B1/en not_active Expired - Lifetime
- 2003-10-07 AT AT03751038T patent/ATE369136T1/de active
- 2003-10-07 ES ES03751038T patent/ES2289316T3/es not_active Expired - Lifetime
- 2003-10-07 PL PL03375584A patent/PL375584A1/xx not_active Application Discontinuation
- 2003-10-07 US US10/530,794 patent/US20060122180A1/en not_active Abandoned
- 2003-10-07 AU AU2003269259A patent/AU2003269259B2/en not_active Ceased
- 2003-10-07 DE DE60315490T patent/DE60315490T2/de not_active Expired - Lifetime
- 2003-10-07 WO PCT/GB2003/004347 patent/WO2004035057A1/en active IP Right Grant
- 2003-10-07 KR KR1020057006232A patent/KR20050056238A/ko not_active Application Discontinuation
- 2003-10-07 DK DK03751038T patent/DK1553950T3/da active
- 2003-10-07 CN CNB2003801013102A patent/CN100342853C/zh not_active Expired - Fee Related
- 2003-10-07 RU RU2005114487/15A patent/RU2005114487A/ru unknown
- 2003-10-07 PT PT03751038T patent/PT1553950E/pt unknown
- 2003-10-07 BR BR0315140-9A patent/BR0315140A/pt not_active IP Right Cessation
- 2003-10-07 MX MXPA05003808A patent/MXPA05003808A/es active IP Right Grant
- 2003-10-07 NZ NZ539137A patent/NZ539137A/en not_active IP Right Cessation
- 2003-10-09 TW TW092128113A patent/TW200412971A/zh unknown
- 2003-10-10 MY MYPI20033877A patent/MY135441A/en unknown
- 2003-10-10 AR ARP030103717A patent/AR041595A1/es unknown
- 2003-10-13 UY UY28017A patent/UY28017A1/es not_active Application Discontinuation
-
2004
- 2004-02-18 SA SA04240502A patent/SA04240502B1/ar unknown
-
2005
- 2005-04-04 NO NO20051658A patent/NO20051658L/no not_active Application Discontinuation
- 2005-04-08 ZA ZA200502874A patent/ZA200502874B/en unknown
- 2005-04-26 IS IS7825A patent/IS2473B/is unknown
- 2005-11-28 HK HK05110831A patent/HK1078784A1/xx not_active IP Right Cessation
-
2007
- 2007-10-08 CY CY20071101275T patent/CY1107605T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU2003269259B2 (en) | 2007-03-15 |
CN1703224A (zh) | 2005-11-30 |
UY28017A1 (es) | 2004-04-30 |
ZA200502874B (en) | 2006-02-22 |
MY135441A (en) | 2008-04-30 |
WO2004035057A1 (en) | 2004-04-29 |
SA04240502B1 (ar) | 2008-09-14 |
JP2006510605A (ja) | 2006-03-30 |
CN100342853C (zh) | 2007-10-17 |
TW200412971A (en) | 2004-08-01 |
EP1553950A1 (en) | 2005-07-20 |
HK1078784A1 (en) | 2006-03-24 |
DE60315490T2 (de) | 2008-05-08 |
CA2501959A1 (en) | 2004-04-29 |
MXPA05003808A (es) | 2005-06-08 |
BR0315140A (pt) | 2005-08-16 |
GB0223854D0 (en) | 2002-11-20 |
IS7825A (is) | 2005-04-26 |
AU2003269259A1 (en) | 2004-05-04 |
CY1107605T1 (el) | 2013-03-13 |
KR20050056238A (ko) | 2005-06-14 |
EP1553950B1 (en) | 2007-08-08 |
AR041595A1 (es) | 2005-05-26 |
PL375584A1 (en) | 2005-11-28 |
ATE369136T1 (de) | 2007-08-15 |
RU2005114487A (ru) | 2006-02-10 |
PT1553950E (pt) | 2007-09-26 |
NZ539137A (en) | 2008-01-31 |
US20060122180A1 (en) | 2006-06-08 |
DK1553950T3 (da) | 2007-10-15 |
DE60315490D1 (de) | 2007-09-20 |
IS2473B (is) | 2008-12-15 |
UA82492C2 (uk) | 2008-04-25 |
ES2289316T3 (es) | 2008-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20051658L (no) | Terapeutisk behandling | |
CY1109119T1 (el) | Φαρμακοτεχνικες μορφες παρατεταμενης απελευθερωσης που περιλαμβανουν λαμοτριγινη | |
NO2013007I1 (no) | Dapagliflozin og farmasøytisk akseptable salter derav | |
NO20040968L (no) | Opioidagonistpreparater med frigjorbar og sekvestrert antagonist | |
NO20030596L (no) | Benzimidazolderivater, deres fremstilling og terapeutiske anvendelse | |
NO20051892L (no) | Ny forbindelse | |
NO20051893L (no) | Ny forbindelse | |
HK1076110A1 (en) | Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof | |
CY1105211T1 (el) | Φαρμακευτικοι συνδυασμοι που πepιλαμβανουν εναν ανταγωνιστη του υποδοχεα p2τ και μελαγατρανη | |
NO20051983D0 (no) | 3-fenyl-substituert pyridoindolon, fremstilling derav og terapeutisk anvendelse derav. | |
DK1161434T3 (da) | Pyridopyranoazepinderivater, deres fremstilling og terapeutiske anvendelse | |
DE69814394D1 (de) | Verwendung von levobupivacain | |
IS2259B (is) | Aðferð til meðferðar á netjuhersli með notkun mótlyfs við integríninu alfa-4 undireiningunni | |
MY137620A (en) | Therapeutic treatment | |
DK1417189T3 (da) | Acylaminothiazolderivater, fremstilling og terapeutisk anvendelse heraf | |
CY1109001T1 (el) | Οι καππα-οπιοιδεις αγωνιστες στη θεραπεια των παθησεων της κυστης | |
PT1525193E (pt) | Derivados do acilaminotiazole e sua utilização como inibidores de beta amilóide | |
IS2487B (is) | Asýloxýpýrrólidín afleiður, framleiðsla og meðferðarnotkun þar á | |
DE60305053D1 (de) | Pyrimidinderivate als selektive cox-2-inhibitoren | |
MY136976A (en) | Novel use of (r)-(-)-2-[5-(4- flourophenyl) -3-pyridylmethylaminomethyl]- chromane and its physiologically acceptable salts | |
NO993546L (no) | 1,4-dihydropyridinderivater og deres anvendelse i terapi | |
ITMI20022594A1 (it) | Combinazione terapeutica per la cura dell'ipertensione. | |
DK1309594T3 (da) | Benzimidazolderivater, fremstilling heraf og terapeutisk anvendelse heraf | |
ES1053617Y (es) | Alfombrilla de uso terapeutico y de higiene personal. | |
SI1525198T1 (sl) | Derivati aciloksi pirolidina in njihova uporaba kot ligandi receptorjev V1b ali V1b in V1a od AVP |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |